Original Research
Published on 08 Feb 2024
ERBB2 (HER2) amplifications and co-occurring KRAS alterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibition
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1339302
- 9,715 views
- 10 citations



